RCAMU
GSK icon

Rothschild & Co Asset Management US’s GSK GSK Stock Holding History

Rothschild & Co Asset Management US’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-6,290
Closed -$341K – 550
2016
Q2 		$341K Buy
6,290
+709
+13% +$37.4K 0.01% 533
2016
Q1 		$283K Buy
+5,581
New +$278K 0.01% 493

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Rothschild & Co Asset Management US's GSK Position: Q3 2016 in Review

Rothschild & Co Asset Management US sold out of GSK (GSK) in Q3 2016, closing a stake of 6,290 shares — an estimated $341K sold.

Rothschild & Co Asset Management US first reported a position in GSK in Q1 2016 and held it in 2 quarters. The position peaked at $341K in Q2 2016. 740 funds tracked by Wall St. Rank hold GSK as of Q3 2016.

  • Rothschild & Co Asset Management US reported no remaining GSK position as of Q3 2016 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 6,290 GSK shares in Q3 2016, an estimated $341K.
  • Rothschild & Co Asset Management US first reported a position in GSK in Q1 2016 and held it in 2 quarters.
  • Rothschild & Co Asset Management US's GSK position peaked at $341K in Q2 2016.
  • 740 funds tracked by Wall St. Rank held GSK as of Q3 2016.

Based on Rothschild & Co Asset Management US's 13F filing for Q3 2016, filed 28 Oct 2016.